Navigation Links
CWRU research examines over-the-counter drug's effect on chemo's side effects
Date:9/19/2011

New research has potential to alleviate the side effects of cancer treatments.

Beth Faiman MSN, CNP, a doctoral candidate at the Frances Payne Bolton School of Nursing at Case Western Reserve University, is studying whether an over-the-counter medication could ease chemotherapy side effects for people with blood and bone marrow cancers.

Faiman has worked as a nurse practitioner since 1994 at the Cleveland Clinic Taussig Cancer Center with patients diagnosed with multiple myeloma. Working with doctors who treat patients and also do research inspired Faiman, she says. "I wanted to be a nurse researcher, and like the doctors, treat patients but also do research to help them."

Faiman needed her PhD to do it. She enrolled in the doctoral program at the Frances Payne Bolton School of Nursing.

As a nurse practitioner and a delegate for the International Myeloma Foundation Nurse Leadership Board, Faiman observed that her patients, with multiple myeloma are surviving cancer with new drug treatments. Unfortunately the treatments caused peripheral neuropathy the nerve damage that leaves some patients with severe numbing, burning or tingling in the hands and feet.

With support from two grantsone from the Oncology Nursing Society and the other from the National Institutes of Health's National Research Service Award program, she will lead the study, "The effect of adjuvant therapy on cancer neuropathy symptoms."

Faiman will enroll 60 patients with multiple myeloma in a double-blind study in which half of the group will receive Glutamine, which has helped some colon and breast cancer patients with their neuropathy. The other half will receive a placebo.

Glutamine can be bought over the counter at drug stores. It is an agent that some patients say alleviates painful symptoms. In cancers like breast and colon, some patients have seen an improvement in these symptoms.

Faiman's concern is that patients may be taking a medication that would interfere with their chemotherapy or that would yield no benefits.

"These individuals with peripheral neuropathy are at risk for falls and other dangers," Faiman says.

Few researchers have yet studied Glutamine's effectiveness, Faiman says, especially, with patients diagnosed with multiple myeloma. She hopes her pioneering effort may give patients additional information as the work to beat cancer and she hopes it will bring her one step closer to the nurse-researcher she aims to be.


'/>"/>

Contact: Susan Griffith
susan.griffith@case.edu
216-368-1004
Case Western Reserve University
Source:Eurekalert

Related medicine news :

1. Researchers identify components that keep immune system in check
2. Researchers identify potential molecular target to prevent growth of cancer cells
3. MRI research demonstrates ALS attacks multiple parts of the brain
4. Research Reveals Why Hungry People Get Cranky
5. Cleveland Clinic researchers awarded NIH grant to study concussion-identifying blood test
6. Put down that Xbox remote: FSU researcher suggests video games may not boost cognition
7. Moffitt researchers find possible key to preventing chemotherapy resistance in ovarian cancer
8. $1.1 million grant targets disparities among medical researchers
9. Yale researchers use uterine stem cells to treat diabetes
10. Wayne State University partners with Toyota on safety research
11. Clemson researchers using interactive vision tool for driving studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... 2017 , ... Resoundant, Inc., the developer of Magnetic ... annual customer education symposium, a world-class learning conference that offers educational content designed ... 31, 2017 at the Atlanta Marriott Marquis in Atlanta, Georgia. , Innovations for ...
(Date:3/28/2017)... ... 2017 , ... The Thyroid Secret is a specialized 9-part ... program was recently launched on March 1, and Dr. Wentz discussed varied benefits ... Dr. Izabella Wentz is a licensed pharmacist and a foremost thyroid specialist. After ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... share of all holidays (IBT World Travel Trends Report). As travelers visit both ... a range in temperatures, and prolonged sun exposure. In response, the outdoor industry ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... the science and clinical practice of radiosurgery, announced today the publication of ... observational registry established to standardize data collection from patients treated with stereotactic ...
(Date:3/28/2017)... ... ... Alert Sentry Group LLC., a leader in the Personal Emergency Response System industry, ... iSAFE Plus. These iSAFE products are the most affordable and most advanced medical alert ... offer direct GPS Location and two-way calling with the push of a button on ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , March 29, 2017 /PRNewswire/ - Medicure Inc. ("Medicure") ... financial results for the year ended December 31, ... 2017. The results are being released later than ... statements will include the operations and balances of ... 2016.  This release and filing date meets TSX ...
(Date:3/28/2017)... March 28, 2017 The global emerging cancer ... of 13.45% from 2016 to 2023 and reach a ... Cancer is a chronic disease and is affecting ... cancer diagnostics market. This report is focused on emerging ... market growth is propelled due to factors such as: ...
(Date:3/28/2017)... 2017 The U.S. Food and Drug ... adults with moderate-to-severe eczema (atopic dermatitis). Dupixent is ... adequately by topical therapies, or those for whom ... used with or without topical corticosteroids. ... approving new and innovative therapies for patients with ...
Breaking Medicine Technology: